Precision medicine in rare diseases: What is next?

B Tesi, C Boileau, KM Boycott… - Journal of Internal …, 2023 - Wiley Online Library
Molecular diagnostics is a cornerstone of modern precision medicine, broadly understood
as tailoring an individual's treatment, follow‐up, and care based on molecular data. In rare …

Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation

A Fraissenon, C Bayard, G Morin… - … England Journal of …, 2024 - Mass Medical Soc
KRAS gain-of-function mutations are frequently observed in sporadic arteriovenous
malformations. The mechanisms underlying the progression of such KRAS-driven …

PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments

GM Morin, L Zerbib, S Kaltenbach… - Annual Review of …, 2024 - annualreviews.org
Recent advances in genetic sequencing are transforming our approach to rare-disease
care. Initially identified in cancer, gain-of-function mutations of the PIK3CA gene are also …

[HTML][HTML] PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis

J Yamaguchi, P Isnard, N Robil, P de la Grange… - The Journal of Clinical …, 2024 - jci.org
Proliferative glomerulonephritis is a severe condition that often leads to kidney failure. There
is a significant lack of effective treatment for these disorders. Here, following the …

PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption

S Ladraa, L Zerbib, C Bayard, A Fraissenon… - Science …, 2022 - science.org
PIK3CA-related overgrowth syndrome (PROS) is a genetic disorder caused by somatic
mosaic gain-of-function mutations of PIK3CA. Clinical presentation of patients is diverse and …

Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition

C Bayard, E Segna, M Taverne, A Fraissenon… - Journal of Experimental …, 2023 - rupress.org
Hemifacial myohyperplasia (HFMH) is a rare cause of facial asymmetry exclusively involving
facial muscles. The underlying cause and the mechanism of disease progression are …

Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth

TL Wenger, S Ganti, C Bull, E Lutsky, JT Bennett… - Genetics in …, 2022 - Elsevier
Purpose PIK3CA-related overgrowth spectrum (PROS) conditions of the head and neck are
treatment challenges. Traditionally, these conditions require multiple invasive interventions …

When, where and which PIK3CA mutations are pathogenic in congenital disorders

A Angulo-Urarte, M Graupera - Nature Cardiovascular Research, 2022 - nature.com
PIK3CA encodes the class I PI3Kα isoform and is frequently mutated in cancer. Activating
mutations in PIK3CA also cause a range of congenital disorders featuring asymmetric tissue …

Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy

A Mansur, I Radovanovic - Frontiers in Neurology, 2023 - frontiersin.org
Vascular malformations are anomalies in vascular development that portend a significant
risk of hemorrhage, morbidity and mortality. Conventional treatments with surgery …

Delineation of the phenotypes and genotypes of PIK3CA-related overgrowth spectrum in East asians

H Chen, B Sun, H Liu, W Gao, Y Qiu, C Hua… - Molecular Genetics and …, 2024 - Springer
PIK3CA-related overgrowth spectrum (PROS) is an umbrella term to describe a diverse
range of developmental disorders. Research to date has predominantly emerged from …